Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: Results from a prospective randomized controlled study (the second year of the SURPRISE study)
Kaneko Y et al. Ann Rheum Dis 2018. doi: 10.1136/annrheumdis-2018-213416
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.